Jump to content

Fladrafinil

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Parsley Man (talk | contribs) at 00:16, 22 November 2016 (References). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Fladrafinil
Clinical data
Other namesFluorafinil, Fladrafinil
Routes of
administration
Oral
ATC code
  • none
Legal status
Legal status
  • US: Not approved
Identifiers
  • 2-{[Bis(4-fluorophenyl)methyl]sulfinyl}-N-hydroxyacetamide
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC15H13F2NO3S
Molar mass325.33 g/mol g·mol−1
3D model (JSmol)
  • C1=CC(=CC=C1C(C2=CC=C(C=C2)F)S(=O)CC(=O)NO)F
  • InChI=1S/C15H13F2NO3S/c16-12-5-1-10(2-6-12)15(22(21)9-14(19)18-20)11-3-7-13(17)8-4-11/h1-8,15,20H,9H2,(H,18,19) ☒N
  • Key:VKGUUSVYPXTWMA-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

CRL-40,941 (also known as fladrafinil and fluorafinil) is a wakefulness-promoting agent closely related to adrafinil and modafinil. It is the bis(p-fluoro) ring-substituted derivative of adrafinil. CRL-40,941 was found to produce antiaggressive effects in animals, which adrafinil does not produce.[1]

See also

References

  1. ^ US patent 4489095, Lafon, L., "Halogenobenzhydrylsulfinylacetohydroxamic Acids", issued 1984-12-18, assigned to Laboratoire L. Lafon